HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nicola Pimpinelli Selected Research

Cytokines

1/2021Second neoplasm in cutaneous T-cell lymphoma patients: a marker of worse prognosis?
1/2006Stem cell factor affects tumour progression markers in metastatic melanoma cells.
10/2005Skin cancer and immunosuppression.
6/2004Atypical CD30+ cutaneous lymphoid proliferation in a patient with tuberculosis infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nicola Pimpinelli Research Topics

Disease

19Melanoma (Melanoma, Malignant)
02/2024 - 12/2004
12Neoplasms (Cancer)
02/2024 - 01/2003
8Mycosis Fungoides
11/2023 - 12/2005
6Psoriasis (Pustulosis Palmaris et Plantaris)
02/2024 - 04/2013
6Lymphoma (Lymphomas)
06/2021 - 02/2003
5Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
11/2023 - 12/2005
4Wounds and Injuries (Trauma)
07/2022 - 03/2018
4Neoplasm Metastasis (Metastasis)
01/2021 - 01/2006
4B-Cell Lymphoma (Lymphoma, B Cell)
08/2014 - 03/2006
3Sezary Syndrome (Sezary Erythroderma)
10/2023 - 12/2005
2Leg Ulcer
04/2024 - 06/2016
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2023 - 03/2008
2Varicose Ulcer (Ulcer, Venous)
06/2021 - 03/2018
2Atopic Dermatitis (Atopic Eczema)
01/2021 - 06/2020
2Skin Diseases (Skin Disease)
01/2019 - 01/2002
2Disease Progression
01/2019 - 05/2017
2Neuroendocrine Carcinoma
07/2009 - 01/2003
1Inflammation (Inflammations)
02/2024
1Hyperpigmentation
01/2023
1Contact Dermatitis (Eczema, Contact)
01/2023
1Monoclonal Gammopathy of Undetermined Significance
10/2021
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2021
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
06/2020
1Erythema
12/2019
1Dermatitis
08/2019
1Squamous Cell Carcinoma of Head and Neck
08/2019
1Head and Neck Neoplasms (Head and Neck Cancer)
08/2019
1Dermatitis Herpetiformis (Disease, Duhring's)
01/2019
1Skin Manifestations
01/2019
1Hematologic Neoplasms (Hematological Malignancy)
01/2019
1Hidradenitis Suppurativa
01/2019
1Acne Vulgaris
12/2016
1Pain (Aches)
12/2016
1Seborrheic Dermatitis
12/2016

Drug/Important Bio-Agent (IBA)

61-phenyl-3,3-dimethyltriazene (PDT)IBA
07/2022 - 03/2006
4CytokinesIBA
01/2021 - 06/2004
3InterferonsIBA
08/2014 - 04/2013
2Immune Checkpoint InhibitorsIBA
02/2024 - 10/2021
2Matrix Metalloproteinases (MMPs)IBA
10/2023 - 01/2003
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
10/2023 - 01/2022
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2022 - 04/2013
2Brentuximab VedotinIBA
06/2021 - 01/2021
2VemurafenibIBA
01/2019 - 11/2017
2Peptides (Polypeptides)IBA
01/2019 - 07/2015
2betamethasone-17,21-dipropionate (betamethasone dipropionate)FDA LinkGeneric
11/2017 - 01/2002
2Adrenal Cortex Hormones (Corticosteroids)IBA
11/2017 - 01/2002
2Bexarotene (LGD1069)FDA Link
01/2016 - 04/2013
2Cadherins (E-Cadherin)IBA
12/2014 - 07/2009
2Interferon-alpha (Interferon Alfa)IBA
08/2014 - 04/2013
2liposomal doxorubicin (Doxil)FDA Link
03/2009 - 05/2007
2Proteins (Proteins, Gene)FDA Link
12/2004 - 02/2003
1Interleukin InhibitorsIBA
02/2024
1mogamulizumabIBA
10/2023
1Mechlorethamine (Nitrogen Mustard)FDA Link
01/2023
1Irritants (Vesicants)IBA
01/2023
1pembrolizumabIBA
10/2021
1NivolumabIBA
10/2021
1Immunoglobulin M (IgM)IBA
10/2021
1NeuropeptidesIBA
06/2021
1Interleukin-23 (Interleukin 23)IBA
01/2021
1Interleukin-5 (Interleukin 5)IBA
01/2021
1dupilumabIBA
01/2021
1Complement System Proteins (Complement)IBA
01/2021
1Monoclonal AntibodiesIBA
01/2021
1Interleukin-17 (Interleukin 17)IBA
01/2021
1Interleukin-13IBA
01/2021
1Interleukin-22 (IL-22)IBA
01/2021
1Glutathione (Reduced Glutathione)IBA
12/2019
1AlginatesIBA
08/2019
1Cetuximab (Erbitux)FDA Link
08/2019
1Biomarkers (Surrogate Marker)IBA
01/2019
1Rifampin (Rifampicin)FDA LinkGeneric
01/2019
1Glutens (Glutelin)IBA
01/2019
1Prostaglandins AIBA
01/2019
1Immunoglobulin A (IgA)IBA
01/2019
1Clindamycin (Cleocin)FDA LinkGeneric
01/2019
1IntegrinsIBA
01/2019
1DecitabineFDA Link
01/2019
1W 12IBA
01/2019
1Anti-Bacterial Agents (Antibiotics)IBA
01/2019
1Urokinase Plasminogen Activator ReceptorsIBA
01/2019
1Transforming Growth Factor beta (TGF-beta)IBA
03/2018
1calcipotriene (calcipotriol)FDA LinkGeneric
11/2017
1EverolimusFDA Link
11/2017
1Vitamin DFDA LinkGeneric
11/2017
1Acetic Acid (Vinegar)FDA LinkGeneric
12/2016
1indoleIBA
12/2016
1AcidsIBA
12/2016
1Photosensitizing Agents (Photosensitizers)IBA
12/2016

Therapy/Procedure

24Therapeutics
02/2024 - 09/2008
5Photochemotherapy (Photodynamic Therapy)
04/2024 - 03/2006
5Radiotherapy
10/2023 - 09/2008
3Immunotherapy
02/2024 - 01/2022
3Phototherapy (Light Therapy)
06/2020 - 10/2018
2Ambulatory Care (Outpatient Care)
06/2020 - 04/2017
2Drug Therapy (Chemotherapy)
09/2008 - 10/2006
1Adjuvant Radiotherapy
12/2023
1Stem Cell Transplantation
06/2021
1Nursing Care
08/2019
1Heterologous Transplantation (Xenotransplantation)
01/2019